PNEUMOCOCCAL SERA ARE ONE OF THE ESSENTIAL STAGES IN THE DESIGN OF EFFECTIVE PROPHYLACTIC PREPARATIONS


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

S. pneumoniae is a cause of many serious invasive and non-invasive diseases. The incidence of these diseases and increasing pathogen resistance to antibacterial drugs determine the topicality of designing effective prophylactic preparations. To monitor circulating strains in different regions and periods is one of the important conditions for solving this problem since immunity is type-specific in pneumococcal infections. There are presently 90 (over 90 according to some investigators’ data) known S. pneumoniae serotypes. The serotype can be determined if an appropriate tool, such as diagnostic pneumococcal sera, is available.

全文:

受限制的访问

作者简介

M. MARKOVA

I.I. Mechnikov Research Institute of Vaccines and Sera, Russian Academy of Medical Sciences

Email: markova-margarit@mail.ru
Moscow

E. ROMANENKO

I.I. Mechnikov Research Institute of Vaccines and Sera, Russian Academy of Medical Sciences

Email: markova-margarit@mail.ru
Moscow

A. LEONOVA

I.I. Mechnikov Research Institute of Vaccines and Sera, Russian Academy of Medical Sciences

Email: markova-margarit@mail.ru
Moscow

E. LEONOVA

I.I. Mechnikov Research Institute of Vaccines and Sera, Russian Academy of Medical Sciences

Email: evgeniya-leonova@mail.ru
Moscow

A. P BATURO

I.I. Mechnikov Research Institute of Vaccines and Sera, Russian Academy of Medical Sciences

Email: markova-margarit@mail.ru
Moscow

参考

  1. Reinert R.R. The antimicrobial resistance profile of Streptococcus pneumoniae. Clin. Microbiol. Infect. 2009; 15(Suppl 3): 7-11.
  2. Баранов А.А., Намазова Л.С., Таточенко В.К. Пневмококковая инфекция и связанние с ней заболевания — серьезная проблема современного здравоохранения. Педиатрическая фармакология 2008; 5(1): 28—33.
  3. Рекомендации расширенного заседания совета экспертов на тему «Бремя пневмококкових заболеваний в России». Врач скорой помощи 2009; 8(2).
  4. Сидоренко С.В., Лобзин Ю.В., Харит С.М., Королева И.С., Таточенко В.К. Пневмококковая инфекция и современние возможности ее профилактики — эпидемиологический обзор ситуации в мире и в России. Вопроси современной терапии 2010; 9(1): 54—61.
  5. Коньюгированная пневмококковая вакцина для иммунизации детей — рекомендации ВОЗ. Педиатрическая фармакология 2007; 4(5): 1—3.
  6. Black R.E., Cousens S., Johnson H.L. et al. Global, regional and national causes of child mortality in 2008: a systematic analysis. Lancet 2010; 375: 1969—1987.
  7. Pneumococcal conjugate vaccine for childhood immunization — WHO position paper. Wkly Epidemiol. Rec. 2007; 82: 93—104.
  8. Adegbola A. Serotype and antimicrobial susceptibility patterns of isolates of S. pneumoniae causing invasive disease in The Gambia 1996—2003. Tropical Medicine and International Health 2006; 11(7): 1128—1135.
  9. Arifeen S.E., Saha S.K., Rahman S. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance. Clin. Infect. Dis. 2009; 48 (Suppl 2): S. 103—113.
  10. Bulter J.C. Epidemiology of pneumococcal serotypes and conjugate vaccine formulations. Microb. Grug Resist. 1997; 3(2): 125—129.
  11. Foster D., Knox K., Walker A.S. Invasive pneumococcal disease: Epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshir region, England. J. Med. Microbiol. 2008; 57(Pt 4): 480—487.
  12. Lynch Jp., Zhanel GG. Streptococcus pneumoniae: epidemiology, risk factors, and strategiers for prevention. Semin. Respir. Crit. Care Med. 2009; 30(2): 189—209.
  13. Maraki S., Mantadakis E., Samonis G. Serotype distribution and antimicrobial resistance of adult Streptococcus pneumoniae clinical isolates over the period 2001—2008 in Crete, Greece. Chemoterapy 2010; 56(4); 325—332.
  14. Pak-Leung Ho, Susan S. Chiu, Maggie Y. Chan. Changes in nasopharengal carriage and serotype distribution of antibiotic-resistant Streptococcus pneumoniae before and after the introduction of 7-valent pneumococcal conjugate vaccine in Hong Kong. Diagn. Microbiol. Infect. Dis. 2011; 10: 1016.
  15. Schnoor M., Hedicke J., Dalhoff K., Raspe H., Schafer T. Approaches to estimate the population-based incidence of community acquired pneumonia. J. Infect. 2007; 55(3): 233—239.
  16. Paarskis I., Kafetzes D.A., Kriz P. Serotypes and antimicrobial susceptibilities of 1033 pneumococci isolate from children in Greece during 2001—2004. Clin. Microbiol. Infect. 2006; 12(5): 490—493.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##